<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Slit ventricle syndrome is characterized by <z:hpo ids='HP_0011010'>chronic</z:hpo> or recurring <z:hpo ids='HP_0002315'>headaches</z:hpo> associated with subnormal ventricular volume in patients who have undergone shunt treatment for <z:hpo ids='HP_0000238'>hydrocephalus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>There appear to be at least three pathophysiological mechanisms that cause this syndrome: 1) intermittent shunt malfunction; 2) intracranial <z:hpo ids='HP_0002615'>hypotension</z:hpo>; and 3) paroxysms of <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> in the presence of <z:mpath ids='MPATH_458'>normal</z:mpath> shunt function </plain></SENT>
<SENT sid="2" pm="."><plain>To treat seven patients with slit ventricle syndrome caused by paroxysms of <z:e sem="disease" ids="C0151740" disease_type="Disease or Syndrome" abbrv="">elevated intracranial pressure</z:e>, we successfully used antimigraine therapy rather than standard calvarial expansion procedures </plain></SENT>
<SENT sid="3" pm="."><plain>None of these patients has required shunt revision or calvarial expansion during a mean follow-up period of 2 years </plain></SENT>
<SENT sid="4" pm="."><plain>The symptoms of slit ventricle syndrome may be a form of "acquired" <z:hpo ids='HP_0002076'>migraine</z:hpo> in shunt patients </plain></SENT>
<SENT sid="5" pm="."><plain>We suggest that, in clinically stable patients with <z:mpath ids='MPATH_458'>normal</z:mpath> shunt function, treatment against <z:hpo ids='HP_0002076'>migraine</z:hpo> may stabilize symptoms resulting from paroxysms of <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Such treatment may prevent unnecessary shunt revisions and/or calvarial expansion procedures </plain></SENT>
</text></document>